Rajeev Saggar
Hoofd Techniek/Wetenschap/O&O bij LIQUIDIA CORPORATION
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Rajeev Saggar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LIQUIDIA CORPORATION | Hoofd Techniek/Wetenschap/O&O | 18-07-2022 | - |
Loopbaan van Rajeev Saggar
Eerdere bekende functies van Rajeev Saggar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 | 01-07-2022 |
The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Opleiding van Rajeev Saggar
University of California, Irvine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Beurs
- Insiders
- Rajeev Saggar
- Ervaring